<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Highly adhesive <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (VWF) multimer induces platelet aggregation and leukocyte tethering or extravasation on the injured vascular wall, contributing to microvascular plugging and <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>-reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>A disintegrin and metalloproteinase with thrombospondin type-1 motifs 13 (ADAMTS13) cleaves the VWF multimer strand and reduces its prothrombotic and proinflammatory functions </plain></SENT>
<SENT sid="2" pm="."><plain>Although ADAMTS13 deficiency is known to amplify post-ischemic <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e>, there is no report available on the effect of ADAMTS13 on <z:mp ids='MP_0001845'>inflammation</z:mp> after <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated if ADAMTS13 deficiency intensifies the increase of extracellular HMGB1, a hallmark of post-<z:hpo ids='HP_0001297'>stroke</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp>, and exacerbates brain injury after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>ADAMTS13 gene knockout (KO) and <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) mice were subjected to 30-min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and 23.5-h reperfusion under continuous monitoring of regional cerebral blood flow (rCBF) </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, plasma high-mobility group box1 (HMGB1) level, and immunoreactivity of the ischemic cerebral cortical tissue (double immunofluorescent labeling) against HMGB1/NeuN (neuron-specific nuclear protein) or HMGB1/MPO (myeloperoxidase) were estimated 24 h after MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>ADAMTS13KO mice had larger brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> compared with WT 24 h after MCAO (p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>The rCBF during reperfusion decreased more in ADAMTS13KO mice </plain></SENT>
<SENT sid="8" pm="."><plain>The plasma HMGB1 increased more in ADAMTS13KO mice than in WT after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion (p &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">Brain ischemia</z:e> induced more prominent activation of inflammatory cells co-expressing HMGB1 and MPO and more marked neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the cortical ischemic penumbra of ADAMTS13KO mice </plain></SENT>
<SENT sid="10" pm="."><plain>ADAMTS13 deficiency may enhance systemic and <z:mp ids='MP_0001847'>brain inflammation</z:mp> associated with HMGB1 neurotoxicity, and aggravate brain damage in mice after brief focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>We hypothesize that ADAMTS13 protects brain from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury by regulating VWF-dependent <z:mp ids='MP_0001845'>inflammation</z:mp> as well as microvascular plugging </plain></SENT>
</text></document>